Featured Research

from universities, journals, and other organizations

HIV treatment while incarcerated helped prisoners achieve viral suppression

Date:
March 31, 2014
Source:
The JAMA Network Journals
Summary:
Treating inmates for the human immunodeficiency virus while they were incarcerated helped a majority of them achieve viral suppression by the time they were released. "We should take fullest advantage of the incarceration period, when people can receive supervised treatment, to improve their health and to develop discharge plans that will maintain these benefits on the outside," an expert concludes.

Treating inmates for the human immunodeficiency virus (HIV) while they were incarcerated in Connecticut helped a majority of them achieve viral suppression by the time they were released.

Related Articles


Of the 1.2 million people living with HIV in the United States, about one-sixth of them will be incarcerated annually, and HIV prevalence is three-fold greater in prisons compared with community settings.

The authors evaluated HIV treatment outcomes during incarceration by studying 882 HIV-infected prisoners with 1,185 incarceration periods in the Connecticut Department of Corrections (2005-2012). The inmates were incarcerated for at least 90 days, had laboratory results regarding their infection, and were prescribed antiretroviral therapy (ART). Most of the inmates were men with an average age of nearly 43 years. Almost half were black.

While 29.8 percent of inmates began their incarceration having already achieved viral suppression (HIV viral load <400 copies/ml), 70 percent of the inmates achieved viral suppression before release. Viral suppression was attained regardless of age, race/ethnicity, duration of incarceration or type of ART regimen.

"Treatment for HIV within prison is facilitated by a highly structured environment and, when combined with simple well-tolerated ART regimens, can result in viral suppression during incarceration," the researchers noted.

Commentary: Progress in Human Immunodeficiency Virus Care in Prisons

In a related commentary, Michael Puisis, D.O., a correctional consultant from Evanston, Ill., writes: "Unfortunately, the features of the excellent correctional care provided to HIV-infected persons in this Connecticut system are not available to all of the estimated 20,000 HIV-infected persons incarcerated in federal or state facilities."

"While the Connecticut study is a positive accomplishment, HIV care in correctional centers still needs improvement in several areas," Puisis continues.

"We should take fullest advantage of the incarceration period, when people can receive supervised treatment, to improve their health and to develop discharge plans that will maintain these benefits on the outside," Puisis concludes.


Story Source:

The above story is based on materials provided by The JAMA Network Journals. Note: Materials may be edited for content and length.


Journal References:

  1. Jaimie P. Meyer, Javier Cepeda, Johnny Wu, Robert L. Trestman, Frederick L. Altice, Sandra A. Springer. Optimization of Human Immunodeficiency Virus Treatment During Incarceration. JAMA Internal Medicine, 2014; DOI: 10.1001/jamainternmed.2014.601
  2. Michael Puisis. Progress in Human Immunodeficiency Virus Care in Prisons. JAMA Internal Medicine, 2014; DOI: 10.1001/jamainternmed.2014.521

Cite This Page:

The JAMA Network Journals. "HIV treatment while incarcerated helped prisoners achieve viral suppression." ScienceDaily. ScienceDaily, 31 March 2014. <www.sciencedaily.com/releases/2014/03/140331170555.htm>.
The JAMA Network Journals. (2014, March 31). HIV treatment while incarcerated helped prisoners achieve viral suppression. ScienceDaily. Retrieved March 29, 2015 from www.sciencedaily.com/releases/2014/03/140331170555.htm
The JAMA Network Journals. "HIV treatment while incarcerated helped prisoners achieve viral suppression." ScienceDaily. www.sciencedaily.com/releases/2014/03/140331170555.htm (accessed March 29, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, March 29, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com
WH Plan to Fight Antibiotic-Resistant Germs

WH Plan to Fight Antibiotic-Resistant Germs

AP (Mar. 27, 2015) The White House on Friday announced a five-year plan to fight the threat posed by antibiotic-resistant bacteria amid fears that once-treatable germs could become deadly. (March 27) Video provided by AP
Powered by NewsLook.com
House Ready to Pass Medicare Doc Bill

House Ready to Pass Medicare Doc Bill

AP (Mar. 26, 2015) In rare bipartisan harmony, congressional leaders pushed a $214 billion bill permanently blocking physician Medicare cuts toward House passage Thursday, moving lawmakers closer to resolving a problem that has plagued them for years. (March 26) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins